Persistent fasting lipogenesis links impaired ketogenesis with citrate synthesis in humans with nonalcoholic fatty liver
Open accessThe DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index.
Abstract
BACKGROUNDHepatic de novo lipogenesis (DNL) and β-oxidation are tightly coordinated, and their dysregulation is thought to contribute to the pathogenesis of nonalcoholic fatty liver (NAFL). Fasting normally relaxes DNL-mediated inhibition of hepatic β-oxidation, dramatically increasing ketogenesis and decreasing reliance on the TCA cycle. Thus, we tested whether aberrant oxidative metabolism in fasting NAFL subjects is related to the inability to halt fasting DNL.METHODSForty consecutive nondiabetic individuals with and without a history of NAFL were recruited for this observational study. After phenotyping, subjects fasted for 24 hours, and hepatic metabolism was interrogated using a combination of 2H2O and 13C tracers, magnetic resonance spectroscopy, and high-resolution mass spectrometry.RESULTSWithin a subset of subjects, DNL was detectable after a 24-hour fast and was more prominent in those with NAFL, though it was poorly correlated with steatosis. However, fasting DNL negatively correlated with hepatic β-oxidation and ketogenesis and positively correlated with citrate synthesis. Subjects with NAFL but undetectable fasting DNL (25th percentile) were comparatively normal. However, those with the highest fasting DNL (75th percentile) were intransigent to the effects of fasting on the concentration of insulin, non-esterified fatty acid, and ketones. Additionally, they sustained glycogenolysis and were spared the loss of oxaloacetate to gluconeogenesis in favor of citrate synthesis, which correlated with DNL and diminished ketogenesis.CONCLUSIONMetabolic flux analysis in fasted subjects indicates that shared metabolic mechanisms link the dysregulations of hepatic DNL, ketogenesis, and the TCA cycle in NAFL.TRIAL REGISTRATIONData were obtained during the enrollment/non-intervention phase of Effect of Vitamin E on Non-Alcoholic Fatty Liver Disease, ClinicalTrials.gov NCT02690792.FUNDINGThis work was supported by the University of Texas Southwestern NORC Quantitative Metabolism Core (NIH P30DK127984), the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078184, R01DK128168, R01DK087977, R01DK132254, and K01DK133630), the NIH/National Institute on Alcohol Abuse and Alcoholism (K01AA030327), and the Robert A. Welch Foundation (I-1804).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Fasting DNL in NAFL subjects is associated with lower ketogenesis and β-oxidation, but increased TCA cycle flux, which preserves estimated hepatic oxygen consumption. (A) Correlation between fasting DNL and ketogenesis measured by in vivo ketone turnover (n = 38), with comparison between subjects without NAFL (non-NAFL) and no DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (B) Correlation between fasting DNL and TCA cycle flux measured by in vivo 13C and 2H isotopomer analysis of plasma glucose (n = 38), with comparison between DNL(–) and Q3 subjects. (C) Correlation between fasting DNL and the fraction of acetyl-CoA partitioned to the TCA cycle (vs. ketogenesis) (n = 36), with comparison between DNL(–) and Q3 subjects. (D) Inverse correlation between fasting DNL and the apparent rate of hepatic β-oxidation, determined as [TCA cycle flux] + [2 × ketogenesis] (n = 36), with a comparison between DNL(–) and Q3 subjects. (E) Oxygen consumption, calculated by flux balance analysis of net NADH/FADH2 production, did not correlate with fasting DNL (n = 36) and did not differ between DNL(–) and Q3 subjects. (F) Schema showing acetyl-CoA partitioning between ketogenesis and the TCA cycle during fasting DNL. The shift to TCA cycle metabolism preserves reducing equivalent flux and oxygen consumption when β-oxidation and ketogenesis are suppressed. e–, electron. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 2 for all groups). Non-correlative data are presented as mean ± SEM.](https://figures.cochat.ai/paper-figures/af65fb9868fa43469700539397eca2d2/persistent-fasting-lipogenesis-links-impaired-ketogenesis-with-citrate-synthesis-figure-2.jpg)
![Figure 3 Subjects with persistent fasting DNL are intransigent to multiple effects of fasting. Fold changes were determined from plasma/serum measurements after an overnight and a 24-hour fast. (A) Expected physiological changes in normal humans transitioning from the fed to the fasting state. (B) Correlation between fasting DNL and the fold decrease in plasma insulin during a 24-hour fast (n = 34), with comparison between subjects without NAFL (Non-NAFL) and DNL [DNL(–)] and NAFL subjects with the highest DNL (Q3). (C) Correlation between fasting DNL and the fold increase in plasma ketones during a 24-hour fast (n = 34), with comparison between DNL(–) and Q3 subjects. (D) Correlation between fasting DNL and the fold increase in plasma non-esterified fatty acids (NEFAs) during a 24-hour fast (n = 36), with comparison between DNL(–) and Q3 subjects. (E) Persistent fasting DNL among NAFL subjects blunts the normal responses of insulin, ketones, and NEFA to fasting. Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA (see Supplemental Figure 3 for all groups). Non-correlative data are presented as mean ± SEM.](https://figures.cochat.ai/paper-figures/59ad585a5d71447cb96d78ed2f1ac539/persistent-fasting-lipogenesis-links-impaired-ketogenesis-with-citrate-synthesis-figure-3.jpg)

![Figure 5 Hepatic oxaloacetate is preferentially utilized for citrate synthesis in subjects with persistent fasting DNL. (A) The competition for oxaloacetate (OAA) by gluconeogenesis (GNG) and citrate synthase impacts the fate of acetyl-CoA. Abundant oxaloacetate facilitates citrate synthase, which outcompetes ketogenesis for acetyl-CoA. The resulting citrate is either oxidized back to oxaloacetate in the TCA cycle or transported from the mitochondria for DNL. (B and C) The absolute rate of gluconeogenesis from oxaloacetate (n = 38) (B) and glycogenolysis (n = 38) (C) was measured by glucose turnover and 2H incorporation into positions C2, C5, and C6 of plasma glucose. (D) A [U-13C3]propionate tracer was used to track oxaloacetate’s relative fate between gluconeogenesis and citrate synthesis. Anaplerosis was traced as [1,2,3-13C] or [2,3,4-13C] oxaloacetate isotopomers, which were diluted to [1,2-13C] or [3,4-13C] isotopomers upon reaction with unlabeled acetyl-CoA in the citrate synthase reaction and a subsequent turn of the TCA cycle (13). These atoms were transmitted to plasma glucose by gluconeogenesis, and isotopomers were detected by 13C-NMR and analysis of the C2 multiplets. (E) Negative correlation between fasting DNL and isotopomers arising from anaplerosis and gluconeogenesis (n = 38). (F) Positive correlation between fasting DNL and isotopomers arising from citrate synthase (n = 38). (G) Negative correlation between fasting DNL and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). (H) Positive correlation between acetyl-CoA used for ketogenesis and the utilization of oxaloacetate for gluconeogenesis relative to its use by citrate synthase (n = 38). Pearson correlations were used to test for statistically significant relationships. Statistical significance between groups was determined using a 1-way ANOVA. Non-correlative data are presented as mean ± SEM.](https://figures.cochat.ai/paper-figures/ac6e63a0308f492e9d55e67de7aaeb00/persistent-fasting-lipogenesis-links-impaired-ketogenesis-with-citrate-synthesis-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial DNL contributes to 15-26% of liver TAGs in individuals with MASLD49,56 vs. 1-6% in the fasting state in healthy individuals.48”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Fasting DNL correlated with plasma TAG concentrations48 and was higher in individuals with MASLD.49”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [48]
In the citing paper
“Fu et al.48 found that DNL was still active after 24 h of fasting in individuals (with or without MASLD) with increased lipolysis but reduced ketone production, indicating a sort of metabolic inflexibility.”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Self-citationDonnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · cited 6×
“%) and [1,2-13 C 2 ]sodium β -hydroxybutyrate (98”
InfluentialNonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · cited 1×
“Tracer studies indicate that excess hepatic TG in NAFL originates from elevated de novo lipogenesis (DNL) (5–9) and the influx of non-esterified fatty acid (NEFA) released from insulin-resistant adipose tissue (10, 11).”
Molecular mediators of hepatic steatosis and liver injury
Browning, J. D., & Horton, J. D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422422 · Cited by 1,772
Self-citationMulti-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610 · cited 2×
“The partitioning of acetyl-CoA between ketogenesis and the TCA cycle is metabolically determined by the rate of β -oxida- tion, availability of free CoA, and the capacity of the TCA cycle to accept acetyl-CoA (24, 25) (Supplemental Figure 1).”
Regulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 5×
“…of ketogenesis provides the periphery with an alternative substrate to dwindling glucose availability, consumes acetyl-CoA, recovers free CoA necessary for accelerated fatty acid processing, and can support an order of magnitude higher rate of β -oxidation than the TCA cycle alone (24, 25).”
InfluentialmTOR Complex 1 Regulates Lipin 1 Localization to Control the SREBP Pathway
Peterson, T. R., Sengupta, S. S., Harris, T. E., Carmack, A. E., Kang, S. A., Balderas, E., Guertin, D. A., Madden, K. L., Carpenter, A. E., Finck, B. N., et al. (2011) · Cell · doi:10.1016/j.cell.2011.06.034 · Cited by 1,229 · cited 2×
“Factors that induce DNL during insulin resistance, such as hyper-insulinemia and mTORC1 signaling, may also stimulate growth pathways, suppress autophagy, and promote hepatomegaly (38, 39), which predicts more severe liver disease (40, 41).”
Lambert, J. E., Ramos–Roman, M. A., Browning, J. D., & Parks, E. J. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.11.049 · Cited by 1,069 · cited 1×
“A parallel study of the same subjects revealed a 4-fold higher rate of DNL (6), suggesting that elevated DNL is closely associated with the activation of TCA cycle metabolism in NAFL subjects, regardless of ketogenic state.”
Self-citationKoliaki, C., Szendroedi, J., Kaul, K., Jelenik, T., Nowotny, P., Jankowiak, F., Herder, C., Carstensen, M., Krausch, M., Knoefel, W. T., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.004 · Cited by 1,032 · cited 3×
“However, tracer studies indicate that NEFA oxidation in the hepatic tricarboxylic acid (TCA) cycle is normal in lean NAFL subjects (19) and increased in obese subjects with NAFL (10, 20–23), findings that parallel studies of ex vivo mitochondrial respiration (12, 14).”
Selective versus Total Insulin Resistance: A Pathogenic Paradox
Brown, M. S., & Goldstein, J. L. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.12.009 · Cited by 965 · cited 3×
“Tracer studies indicate that excess hepatic TG in NAFL originates from elevated de novo lipogenesis (DNL) (5–9) and the influx of non-esterified fatty acid (NEFA) released from insulin-resistant adipose tissue (10, 11).”
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease
Smith, G. I., Shankaran, M., Yoshino, M., Schweitzer, G. G., Chondronikola, M., Beals, J. W., Okunade, A. L., Patterson, B. W., Nyangau, E., Field, T., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134165 · Cited by 771 · cited 2×
“Tracer studies indicate that excess hepatic TG in NAFL originates from elevated de novo lipogenesis (DNL) (5–9) and the influx of non-esterified fatty acid (NEFA) released from insulin-resistant adipose tissue (10, 11).”
A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis.
McGarry, J. D., Mannaerts, G. P., & Foster, D. W. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108764 · Cited by 736 · cited 12×
“Subjects with NAFL in the highest quartile of fasting DNL had the lowest rates of β -oxidation, consistent with the canonical role of malonyl-CoA in regulating mitochondrial NEFA transport (17).”
InfluentialSunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672 · cited 5×
“Previous studies in overnight-fasted individuals, in whom ketogenesis is minimal, also found increased TCA cycle flux in NAFL subjects (10).”
InfluentialSelf-citationMcGarry, J. D., Leatherman, G. F., & Foster, D. W. (1978) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34693-8 · Cited by 600
Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction
Kirk, E., Reeds, D. N., Finck, B. N., Mayurranjan, M. S., Patterson, B. W., & Klein, S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.01.048 · Cited by 440
Kim, C.-W., Addy, C., Kusunoki, J., Anderson, N. N., Deja, S., Fu, X., Burgess, S. C., Li, C., Ruddy, M., Chakravarthy, M., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.009 · Cited by 419
Self-citationIncreased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men
Petersen, K. F., Dufour, S., Feng, J., Befroy, D., Dziura, J., Man, C. D., Cobelli, C., & Shulman, G. I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608537103 · Cited by 403 · cited 5×
“Sterility-and pyrogen-tested [3,4-13 C 2 ]ethylacetoacetate (98”
InfluentialBrowning, J. D., Baker, J. A., Rogers, T., Davis, J., Satapati, S., & Burgess, S. C. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.007674 · Cited by 328
Self-citationInfluence of body fat content and distribution on variation in metabolic risk
Vega, G. L., Adams-Huet, B., Peshock, R., Willett, D., Shah, B., & Grundy, S. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0814 · Cited by 312
The regulation of the release of ketone bodies by the liver
Krebs, H. A. (1966) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(66)90027-6 · Cited by 259 · cited 3×
“A shift in the fate of acetyl-CoA from the TCA cycle to ketogen-esis occurs when hepatic oxaloacetate is depleted by gluconeogenesis and other factors during fasting (27), which limits citrate synthase flux and promotes the partitioning of acetyl-CoA to ketones (34, 35) (Figure 5A).”
Moore, M. P., Cunningham, R. P., Meers, G. M., Johnson, S. A., Wheeler, A. A., Ganga, R. R., Spencer, N. M., Pitt, J. B., Diaz‐Arias, A., Swi, A. I. A., et al. (2022) · Hepatology · doi:10.1002/hep.32324 · Cited by 240 · cited 3×
“However, tracer studies indicate that NEFA oxidation in the hepatic tricarboxylic acid (TCA) cycle is normal in lean NAFL subjects (19) and increased in obese subjects with NAFL (10, 20–23), findings that parallel studies of ex vivo mitochondrial respiration (12, 14).”
Lawitz, E. J., Coste, A., Poordad, F., Alkhouri, N., Loo, N., McColgan, B. J., Tarrant, J. M., Nguyen, T., Han, L., Chung, C., et al. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.04.042 · Cited by 217
Splanchnic glucose and amino acid metabolism in obesity.
Felig, P., Wahren, J., Hendler, R., & Brundin, T. (1974) · Journal of Clinical Investigation · doi:10.1172/jci107593 · Cited by 211
Ketogenesis prevents diet-induced fatty liver injury and hyperglycemia
Cotter, D. G., Ercal, B., Huang, X., Leid, J. M., d’Avignon, D. A., Graham, M. J., Dietzen, D. J., Brunt, E. M., Patti, G. J., & Crawford, P. A. (2014) · Journal of Clinical Investigation · doi:10.1172/jci76388 · Cited by 201 · cited 1×
“Notably, ketogenic insufficiency results in more significant hepatic injury in mice (45), perhaps due to the preferential synthesis of cytotoxic lipid species (44).”
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Fletcher, J. A., Deja, S., Satapati, S., Fu, X., Burgess, S. C., & Browning, J. D. (2019) · JCI Insight · doi:10.1172/jci.insight.127737 · Cited by 194
Self-citationIns and outs of the TCA cycle: the central role of anaplerosis
Inigo, M., Deja, S., & Burgess, S. C. (2021) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-120420-025558 · Cited by 189
Self-citationAlterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
Petäjä, E., & Yki-Järvinen, H. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050633 · Cited by 144 · cited 2×
“Hepatic steatosis is the primary feature of NAFL, defined as the accumulation of triglyceride (TG) greater than 2%–5% of liver volume (1, 3, 4).”
Diraison, F., Pachiaudi, C., & Beylot, M. (1997) · Journal of Mass Spectrometry · doi:10.1002/(sici)1096-9888(199701)32:1<81::aid-jms454>3.0.co;2-2 · Cited by 123 · cited 1×
“The calculation of DNL was performed as previously described (33) and was based on the formula reported by Beylot and colleagues (52).”
Hyötyläinen, T., Jerby, L., Petäjä, E. M., Mattila, I., Jäntti, S., Auvinen, P., Gastaldelli, A., Yki-Järvinen, H., Ruppin, E., & Orešič, M. (2016) · Nature Communications · doi:10.1038/ncomms9994 · Cited by 114 · cited 1×
“However, tracer studies indicate that NEFA oxidation in the hepatic tricarboxylic acid (TCA) cycle is normal in lean NAFL subjects (19) and increased in obese subjects with NAFL (10, 20–23), findings that parallel studies of ex vivo mitochondrial respiration (12, 14).”
Yang, D., Diraison, F., Beylot, M., Brunengraber, D. Z., Samols, M. A., Anderson, V. E., & Brunengraber, H. (1998) · Analytical Biochemistry · doi:10.1006/abio.1998.2632 · Cited by 113 · cited 1×
“The body water enrichment was measured in plasma by analysis of acetone after exchange under basic conditions (50, 51).”
Jones, J. G., Naidoo, R., Sherry, A. D., Jeffrey, F. M. H., Cottam, G. L., & Malloy, C. R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00764-3 · Cited by 92 · cited 1×
“These data were used to determine relative rates (36).”
Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome
d’Avignon, D. A., Puchalska, P., Ercal, B., Chang, Y., Martin, S. E., Graham, M. J., Patti, G. J., Han, X., & Crawford, P. A. (2018) · JCI Insight · doi:10.1172/jci.insight.99762 · Cited by 90 · cited 3×
“In the context of ketogenic insufficiency, acetyl-CoA generation exceeding cellular energy demand was shunted to lipids following citrate formation rather than conversion to ketones or complete oxidation (44).”
Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
ter Horst, K. W., Vatner, D. F., Zhang, D., Cline, G. W., Ackermans, M. T., Nederveen, A. J., Verheij, J., Demirkiran, A., van Wagensveld, B. A., Dallinga-Thie, G. M., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1644 · Cited by 88
Petersen, K. F., Befroy, D. E., Dufour, S., Rothman, D. L., & Shulman, G. I. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.005 · Cited by 84
Regulation of hepatic mitochondrial oxidation by glucose-alanine cycling during starvation in humans
Petersen, K. F., Dufour, S., Cline, G. W., & Shulman, G. I. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129913 · Cited by 70 · cited 3×
“However, fasting also results in increased hepatic gluconeogenesis, diminishing anaplerotic substrate (e.g., lactate, pyruvate, and amino acids), and a more reduced redox state, factors that deplete the TCA cycle of oxaloacetate and limit citrate synthesis (24, 26).”
Headspace analyses of acetone: A rapid method for measuring the 2H-labeling of water
Shah, V., Herath, K. B., Previs, S. F., Hubbard, B. K., & Roddy, T. P. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.05.010 · Cited by 61 · cited 1×
“The body water enrichment was measured in plasma by analysis of acetone after exchange under basic conditions (50, 51).”
Gancheva, S., Kahl, S., Pesta, D., Mastrototaro, L., Dewidar, B., Strassburger, K., Sabah, E., Esposito, I., Weiß, J., Sarabhai, T., et al. (2022) · Diabetes Care · doi:10.2337/dc21-1758 · Cited by 60 · cited 2×
“Prior ex vivo studies indicate that hepatic mitochondrial respiration is either normal or compensated to higher oxygen consumption in NAFL subjects (12, 14) and eventually declines with advanced disease and the onset of steatohepatitis and/or diabetes (16, 42).”
Hughey, C. C., Puchalska, P., & Crawford, P. A. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2022.159209 · Cited by 57 · cited 2×
“However, fasting ketosis is blunted in several studies, suggesting limited β -oxidation capacity (15).”
Lopes‐Cardozo, M., Mulder, I., van Vugt, F., Hermans, P. G. C., van den Bergh, S. G., Klazinga, W., & Vries-Akkerman, E. A. D. (1975) · Molecular and Cellular Biochemistry · doi:10.1007/bf01751311 · Cited by 54 · cited 1×
“A shift in the fate of acetyl-CoA from the TCA cycle to ketogen-esis occurs when hepatic oxaloacetate is depleted by gluconeogenesis and other factors during fasting (27), which limits citrate synthase flux and promotes the partitioning of acetyl-CoA to ketones (34, 35) (Figure 5A).”
Diraison, F., Large, V., Brunengraber, H., & Beylot, M. (1998) · Diabetologia · doi:10.1007/s001250050892 · Cited by 52
Brundin, T., Thörne, A., & Wahren, J. (1992) · Metabolism · doi:10.1016/0026-0495(92)90190-l · Cited by 51 · cited 1×
“However, tracer studies indicate that NEFA oxidation in the hepatic tricarboxylic acid (TCA) cycle is normal in lean NAFL subjects (19) and increased in obese subjects with NAFL (10, 20–23), findings that parallel studies of ex vivo mitochondrial respiration (12, 14).”
A low-carbohydrate diet rapidly and dramatically reduces intrahepatic triglyceride content
Browning, J. D., Davis, J., Saboorian, H. M., & Burgess, S. C. (2006) · Hepatology · doi:10.1002/hep.21264 · Cited by 47 · cited 1×
“Perhaps for this reason, low-carbohydrate diets and ACC inhibitors, which suppress DNL and enhance ketogenesis, are very effective at reducing hepatic steatosis (28–32).”
Self-citationMeasurement of lipogenic flux by deuterium resolved mass spectrometry
Fu, X., Deja, S., Fletcher, J. A., Anderson, N. N., MIZERSKA, M. N., do Vale, G. D., Browning, J. D., Horton, J. D., McDonald, J. G., Mitsche, M. A., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23958-4 · Cited by 43 · cited 6×
“A fractional DNL of 0.10% was considered to be the lower limit of detection and was used as a cutoff to demarcate those with and without detectable DNL after fasting (33).”
InfluentialSelf-citationLawitz, E., Li, K. W., Nyangau, E., Field, T., Chuang, J.-C., Billin, A. N., Wang, L., Wang, Y., Huss, R. S., Chung, C., et al. (2022) · Journal of Lipid Research · doi:10.1016/j.jlr.2022.100250 · Cited by 38 · cited 2×
“Finally, a recent study of NASH subjects used multiple 2 H 2 O dosing periods and plasma TG-palmitate enrichment measurements over 12 weeks to model lipid turnover (46).”
InfluentialHepatic mTORC1 Opposes Impaired Insulin Action to Control Mitochondrial Metabolism in Obesity
Kucejova, B., Duarte, J., Satapati, S., Fu, X., Ilkayeva, O., Newgard, C. B., Brugarolas, J., & Burgess, S. C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.006 · Cited by 37
Self-citationKetogenesis in isolated rat liver mitochondria. III. Relationship with the rate of β-oxidation
Lopes‐Cardozo, M., & van den Bergh, S. G. (1974) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/0005-2728(74)90111-x · Cited by 32
A simple method to approximate liver size on cross-sectional images using living liver models
Muggli, D., Müller, M., Karlo, C. A., Fornaro, J., Marinček, B., & Frauenfelder, T. (2009) · Clinical Radiology · doi:10.1016/j.crad.2009.02.013 · Cited by 31
Dillman, J. R., Trout, A. T., Costello, E. N., Serai, S. D., Bramlage, K., Kohli, R., & Xanthakos, S. A. (2017) · American Journal of Roentgenology · doi:10.2214/ajr.17.18446 · Cited by 30 · cited 2×
“Factors that induce DNL during insulin resistance, such as hyper-insulinemia and mTORC1 signaling, may also stimulate growth pathways, suppress autophagy, and promote hepatomegaly (38, 39), which predicts more severe liver disease (40, 41).”
Simple diameter measurement as predictor of liver volume and liver parenchymal disease
Seppelt, D., Ittermann, T., Kromrey, M., Kolb, C., vWahsen, C., Heiss, P., Völzke, H., Hoffmann, R., & Kühn, J. (2022) · Scientific Reports · doi:10.1038/s41598-022-04825-8 · Cited by 23 · cited 2×
“Factors that induce DNL during insulin resistance, such as hyper-insulinemia and mTORC1 signaling, may also stimulate growth pathways, suppress autophagy, and promote hepatomegaly (38, 39), which predicts more severe liver disease (40, 41).”
Previs, S. F., Herath, K. B., Nawrocki, A. R., Rodríguez, C. G., Slipetz, D. M., Singh, S. B., Kang, L., Bhat, G., Roddy, T. P., Conarello, S., et al. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00010.2017 · Cited by 15 · cited 1×
“If TG pool dynamics vary between normal and NAFL subjects, then the single 15-hour measurement of TG-pal-mitate enrichment used here may underestimate DNL in subjects with pools of TG that turn over more slowly, as described in previous simulations of hepatic TG dynamics (47).”
Krebs takes a turn at cell differentiation
Deja, S., Crawford, P. A., & Burgess, S. C. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.04.005 · Cited by 13 · cited 2×
“In other words, increased utilization of oxaloacetate for citrate synthesis may partially reflect the reliance of DNL on TCA cycle intermediates (e.g., citrate) for the citrate shuttle (13, 37) and simultaneously diminish ketogenesis (Figure 5A).”
Self-citation
Cited by
Lipid metabolism in MASLD and MASH: From mechanism to the clinic
Carli, F., Della Pepa, G., Sabatini, S., Vidal Puig, A., & Gastaldelli, A. (2024) · JHEP Reports · doi:10.1016/j.jhepr.2024.101185 · Cited by 147
“Fasting DNL correlated with plasma TAG concentrations 48 and was higher in individuals with MASLD.”
Decoding the Liver-Heart Axis in Cardiometabolic Diseases
Capone, F., Vacca, A., Bidault, G., Sarver, D. C., Kamińska, D., Strocchi, S., Vidal‐Puig, A., Greco, C. M., Lusis, A. J., & Schiattarella, G. G. (2025) · Circulation Research · doi:10.1161/circresaha.125.325492 · Cited by 81
Liver-specific actions of GH and IGF1 that protect against MASLD
Kineman, R. D., del Río-Moreno, M., & Waxman, D. J. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-024-01037-0 · Cited by 54
“Of note, an elevation in fasting DNL, with suppressed β-oxidation and keto-genesis, is also seen in patients with MASLD 92 .”
Hepatic adaptation to chronic metabolic stress primes tumorigenesis
Tzouanas, C. N., Shay, J. E. S., Sherman, M. S., Rubin, A. J., Mead, B. E., Dao, T. T., Tao, J., Lehrich, B. M., Eng, G. M., Patterson-Fortin, J., et al. (2025) · Cell · doi:10.1016/j.cell.2025.11.031 · Cited by 38
Liver insulinization as a driver of triglyceride dysmetabolism
Cook, J. R., Hawkins, M. A., & Pajvani, U. B. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00843-6 · Cited by 35
Metadata
- Authors
- Fu, X., Fletcher, J. A., Deja, S., Inigo-Vollmer, M., Burgess, S. C., & Browning, J. D.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Browning, Jeffrey D.
- Venue
- Journal of Clinical Investigation
- Published
- 2023-05-01
- Volume
- 133
- Issue
- 9
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC10145942
- OpenAlex
- W4327626431
- Cited by
- 30
- References
- 53
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 8 · 2023: 3
- FWCI
- 5.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Investigation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Institutes of Health (P30DK127984,R01DK078184,R01DK128168,K01DK133630,K01AA030327)
- Robert A Welch Foundation (I-1804)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- non-alcoholic fatty liver disease, de novo lipogenesis, ketogenesis, hepatic beta-oxidation, citrate synthesis, TCA cycle, fasting, hepatic metabolism, metabolic flux, oxaloacetate, gluconeogenesis, glycogenolysis, insulin resistance, free fatty acids, ketones, steatosis, vitamin E
- MeSH terms
- Citrates, Fasting, Humans, Ketone Bodies, Liver, Citric Acid, Lipogenesis, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.